Attovia Therapeutics, Inc.
NASDAQATTO entered September with a wave of analyst attention it almost certainly didn't have two weeks ago — and a borrow market that tells a very different story from the one shorts were writing in mid-August. The defining event of the week was a sweep of five simultaneous coverage initiations, all published on August 31. Citigroup opened with a Buy and a $30 target. Morgan Stanley…
Snapshot as of 2 Sept 2026
ATTO entered September with a wave of analyst attention it almost certainly didn't have two weeks ago — and a borrow market that tells a very different story from the one shorts were writing in mid-August. The defining…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ATTO — free to start on ORTEX.
Sign up for free →Open ATTO on ORTEX